Scott Swayze, MD, is the chair of the Board of Trustees for Wellstar Health System
Glucagon-like Peptide-1 Receptor Agonists and Ischaemic Heart Disease Ischaemic heart disease is a major risk factor for HF (both HFrEF and HFpEF)
This study was supported by funding from the QUDSGQU Health20261, Qatar University
[DOI] [PubMed] [Google Scholar] 239.Wang J, Carrillo JJ, Lin HV
Physicians prescribe for patients who: Struggle with obesity or difficulty losing weight Have type 2 diabetes or prediabetes Suffer from metabolic syndrome or insulin resistance Experience poor glycemic control despite other treatments Need an alternative to traditional weight loss medications How It Works This GLP-1 mimics the bodys natural incretin hormones, enhancing glucose metabolism, energy regulation, and appetite control
**Made in the USA with domestic and globally sourced ingredients